We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
426
Puma Biotechnology
PBYI
$406M
$2.82M 0.04%
223,200
+208,586
+1,427% +$4.8M
PBCT
427
DELISTED
People's United Financial Inc
PBCT
$2.79M 0.03%
75,963
+20,800
+38% +$345K
MCK icon
428
McKesson
MCK
$98.5B
$2.77M 0.03%
13,675
-2,192
-14% -$273K
NTRS icon
429
Northern Trust
NTRS
$22.2B
$2.76M 0.03%
30,816
+1,915
+7% +$176K
TROW icon
430
T. Rowe Price
TROW
$25B
$2.74M 0.03%
25,097
+194
+0.8% +$20.4K
FISV
431
Fiserv Inc
FISV
$27.2B
$2.73M 0.03%
30,122
FNSR
432
DELISTED
Finisar Corp
FNSR
$2.73M 0.03%
+120,045
New +$2.75M
CTSH icon
433
Cognizant
CTSH
$21.5B
$2.71M 0.03%
42,962
-1,892
-4% -$124K
CBAY
434
DELISTED
Cymabay Therapeutics
CBAY
$2.69M 0.03%
378,000
-600,000
-61% -$6.79M
MLAB icon
435
Mesa Laboratories
MLAB
$539M
$2.69M 0.03%
11,067
+1,000
+10% +$233K
XLNX
436
DELISTED
Xilinx Inc
XLNX
$2.69M 0.03%
22,908
+28
+0.1% +$3.26K
ALDR
437
DELISTED
Alder Biopharmaceuticals
ALDR
$2.67M 0.03%
227,500
KHC icon
438
Kraft Heinz
KHC
$30.4B
$2.64M 0.03%
85,514
+2,617
+3% +$82.5K
INFO
439
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.64M 0.03%
41,668
+4,235
+11% +$243K
PAYX icon
440
Paychex
PAYX
$40.4B
$2.62M 0.03%
32,024
+6,116
+24% +$516K
HBAN icon
441
Huntington Bancshares
HBAN
$35.1B
$2.62M 0.03%
190,160
-4
-0% -$54
ADM icon
442
Archer Daniels Midland
ADM
$41.4B
$2.59M 0.03%
63,659
+2,473
+4% +$102K
TEL icon
443
TE Connectivity
TEL
$58.8B
$2.59M 0.03%
27
-2
-7% -$180
BWA icon
444
BorgWarner
BWA
$13.2B
$2.57M 0.03%
69,833
-34,836
-33% -$1.23M
OGS icon
445
ONE Gas
OGS
$5.05B
$2.55M 0.03%
+28,375
New +$2.51M
HSBC icon
446
HSBC
HSBC
$355B
$2.55M 0.03%
61
+6
+11% +$251
HMC icon
447
Honda
HMC
$36.5B
$2.53M 0.03%
98
+6
+7% +$160
APH icon
448
Amphenol
APH
$188B
$2.53M 0.03%
105,956
+8,860
+9% +$213K
TAP icon
449
Molson Coors Class B
TAP
$7.68B
$2.53M 0.03%
45,378
-71,110
-61% -$4.15M
NUE icon
450
Nucor
NUE
$56.4B
$2.53M 0.03%
46,090
-405
-0.9% -$22.3K

Similar funds

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.